Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Oct 6;17(6):533–545. doi: 10.1159/000527391

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 by S. Karger AG, Basel

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.

PMC Copyright notice

Fig. 1 — a Hormone receptor status distribution within HER2-low breast cancer. Original figure based on data available in the literature [7, 8, 11, 12, 13, 14]. b PAM50 intrinsic subtype distribution in HER2-low tumors. The figure illustrates the percentages of PAM50 intrinsic subtype within HR+/HER2-low and HR−/HER2-low subgroups (i.e., for HR+/HER2-low: luminal A 58.9–65.9%, luminal B 25.4–33.4%, HER2-enriched 1.2–3.0%, basal-like 1.9–3.6%, normal-like 2.8–3.9%. For HR−/HER2-low: luminal A 1.4–1.6%, luminal B 0%, HER2-enriched 7.1–13.7%, basal-like 76.7–83.3%, normal-like 7.9–8.2%). Original figure based on data available in the literature [7, 12]. HR, hormone receptor.